0001209191-19-058709.txt : 20191203
0001209191-19-058709.hdr.sgml : 20191203
20191203162553
ACCESSION NUMBER: 0001209191-19-058709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191129
FILED AS OF DATE: 20191203
DATE AS OF CHANGE: 20191203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iyengar Vijay K
CENTRAL INDEX KEY: 0001670000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 191266073
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-29
0
0000879169
INCYTE CORP
INCY
0001670000
Iyengar Vijay K
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP GPS, BD, & Licensing
Common Stock
2019-11-29
4
M
0
500
72.86
A
18109
D
Common Stock
2019-11-29
4
S
0
500
95.00
D
17609
D
Common Stock
2019-12-02
4
M
0
7366
72.86
A
24975
D
Common Stock
2019-12-02
4
S
0
7366
95.00
D
17609
D
Non-Qualified Stock Option (right to buy)
72.86
2019-11-29
4
M
0
500
0.00
D
2023-05-08
Common Stock
500
23098
D
Non-Qualified Stock Option (right to buy)
72.86
2019-12-02
4
M
0
7366
0.00
D
2023-05-08
Common Stock
7366
15732
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
This includes an aggregate of 12,562 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
Beginning May 9, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
/s/ Vijay Iyengar
2019-12-03